Charles River Laboratories International Inc (CRL)
227.81
-11.62
(-4.85%)
USD |
NYSE |
Apr 25, 16:00
232.21
+4.40
(+1.93%)
Pre-Market: 20:00
Charles River Laboratories International Revenue (TTM): 4.129B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.129B |
| September 30, 2023 | 4.216B |
| June 30, 2023 | 4.178B |
| March 31, 2023 | 4.092B |
| December 31, 2022 | 3.976B |
| September 30, 2022 | 3.781B |
| June 30, 2022 | 3.688B |
| March 31, 2022 | 3.630B |
| December 31, 2021 | 3.540B |
| September 30, 2021 | 3.426B |
| June 30, 2021 | 3.273B |
| March 31, 2021 | 3.041B |
| December 31, 2020 | 2.924B |
| September 30, 2020 | 2.824B |
| June 30, 2020 | 2.749B |
| March 31, 2020 | 2.724B |
| December 31, 2019 | 2.621B |
| September 30, 2019 | 2.532B |
| June 30, 2019 | 2.449B |
| March 31, 2019 | 2.377B |
| December 31, 2018 | 2.266B |
| September 30, 2018 | 2.143B |
| June 30, 2018 | 2.022B |
| March 31, 2018 | 1.906B |
| December 31, 2017 | 1.858B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.846B |
| June 30, 2017 | 1.807B |
| March 31, 2017 | 1.772B |
| December 31, 2016 | 1.681B |
| September 30, 2016 | 1.568B |
| June 30, 2016 | 1.492B |
| March 31, 2016 | 1.398B |
| December 31, 2015 | 1.363B |
| September 30, 2015 | 1.339B |
| June 30, 2015 | 1.317B |
| March 31, 2015 | 1.319B |
| December 31, 2014 | 1.298B |
| September 30, 2014 | 1.257B |
| June 30, 2014 | 1.222B |
| March 31, 2014 | 1.174B |
| December 31, 2013 | 1.166B |
| September 30, 2013 | 1.156B |
| June 30, 2013 | 1.143B |
| March 31, 2013 | 1.135B |
| December 31, 2012 | 1.130B |
| September 30, 2012 | 1.140B |
| June 30, 2012 | 1.139B |
| March 31, 2012 | 1.143B |
| December 31, 2011 | 1.143B |
| September 30, 2011 | 1.133B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.449B
Minimum
Jun 2019
4.216B
Maximum
Sep 2023
3.358B
Average
3.426B
Median
Sep 2021
Revenue (TTM) Benchmarks
| Cardinal Health Inc | 216.15B |
| Stryker Corp | 20.50B |
| DaVita Inc | 12.14B |
| Inotiv Inc | 585.17M |
| Medpace Holdings Inc | 1.963B |